Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZEK
1551
DELISTED
The AZEK Co
AZEK
| $23.6M | 0.01% |
612,592
-160,038
| -21% | -$5.78M |
|
1552
CALL
Ferrari
RACE
$72.9B
| $23.5M | 0.01% |
102,600
+27,300
| +36% | +$5.57M |
|
1553
CALL
VanEck Oil Services ETF
OIH
$2B
| $23.5M | 0.01% |
152,840
-33,860
| -18% | -$4.3M |
|
1554
PUT
Edwards Lifesciences
EW
$52.8B
| $23.5M | 0.01% |
257,600
+25,400
| +11% | +$2.11M |
|
1555
Royal Bank of Canada
RY
$301B
| $23.3M | 0.01% |
284,484
-260,140
| -48% | -$20.1M |
|
1556
CALL
Dave & Buster's
PLAY
$354M
| $23.3M | 0.01% |
776,900
-2,300
| -0.3% | -$51.1K |
|
1557
CALL
AB InBev
BUD
$157B
| $23.3M | 0.01% |
332,800
-53,500
| -14% | -$3.38M |
|
1558
CALL
Oneok
OKE
$59.9B
| $23.1M | 0.01% |
602,100
+164,600
| +38% | +$5.53M |
|
1559
CALL
Truist Financial
TFC
$64.9B
| $23.1M | 0.01% |
481,971
-245,129
| -34% | -$11.1M |
|
|
ZEN
1560
DELISTED
ZENDESK INC
ZEN
| $23.1M | 0.01% |
161,345
-81,886
| -34% | -$10.2M |
|
1561
Arrowhead Research
ARWR
$12.2B
| $23.1M | 0.01% |
300,872
+34,890
| +13% | +$2.23M |
|
|
TECX
1562
Tectonic Therapeutic
TECX
$682M
| $23.1M | 0.01% |
137,892
-14,909
| -10% | -$2.65M |
|
|
TTCF
1563
PUT
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $23.1M | 0.01% |
1,007,600
+219,200
| +28% | +$4.33M |
|
1564
PUT
Teva Pharmaceuticals
TEVA
$42.8B
| $23M | 0.01% |
2,386,900
+219,700
| +10% | +$2.1M |
|
|
ZNGA
1565
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $23M | 0.01% |
2,329,500
+1,080,800
| +87% | +$9.73M |
|
1566
KB Home
KBH
$3.44B
| $22.9M | 0.01% |
683,888
+43,592
| +7% | +$1.57M |
|
1567
Xcel Energy
XEL
$49.5B
| $22.9M | 0.01% |
343,843
-1,548,341
| -82% | -$108M |
|
1568
CALL
Hershey
HSY
$37B
| $22.9M | 0.01% |
150,400
-40,100
| -21% | -$5.93M |
|
|
CERE
1569
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $22.9M | 0.01% |
+1,381,556
| New | +$17.9M |
|
|
RAD
1570
PUT
DELISTED
Rite Aid Corporation
RAD
| $22.9M | 0.01% |
1,446,920
-101,880
| -7% | -$1.31M |
|
|
CHX
1571
DELISTED
ChampionX
CHX
| $22.9M | 0.01% |
1,495,266
-3,302,161
| -69% | -$36.7M |
|
1572
PUT
Fulgent Genetics
FLGT
$511M
| $22.9M | 0.01% |
438,600
+371,000
| +549% | +$15.5M |
|
1573
PUT
Apollo Global Management
APO
$83.1B
| $22.8M | 0.01% |
466,500
-42,200
| -8% | -$1.88M |
|
1574
Ford
F
$57.3B
| $22.8M | 0.01% |
2,597,210
-5,542,536
| -68% | -$46.4M |
|
1575
M&T Bank
MTB
$36.7B
| $22.7M | 0.01% |
178,652
-116,064
| -39% | -$13.2M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.